Abstract:
Provided is a method for preparing a novel polylactide/clay nanocomposite which is improved in shear thinning and toughness by enhancing a plasticization effect and can be applied to a biodegradable resin of polylactide. The method comprises the steps of pretreating a clay having a hydroxyl group at surface with a ring opening polymerization catalyst; adding a lactide-based monomer and a caprolactone-based monomer to the pretreated clay and increasing the reaction system to carry out the surface modification reaction of the clay; and melt mixing the obtained clay with a polylactide having a number average molecular weight of 50,000 or more to prepare a polylactide/clay nanocomposite. Preferably the ring opening polymerization catalyst is at least one organometallic catalyst of Sn, Al or rare earth elements.
Abstract:
PURPOSE: An in situ implant composition is provided with a biodegradable polymer containing polyethylene glycol to prevent denaturation of the protein substance within the polymer matrix by forming the movement passage of carboxylic acid, and to control the structure and material property of the polymer by introducing polyethylene glycol. CONSTITUTION: An in situ implant composition contains a biodegradable polymer containing a copolymer of polyethylene glycol and aliphatic polyester, a solvent for dissolving the biodegradable polymer, and a medicament uniformly diffused in the solvent to mediate the biodegradable polymer. The aliphatic polyester polymer is selected from lactic acid, glycolic acid, caprolactone, dioxanone, or trimethyl carbonate. The copolymer is a graft or block copolymer.
Abstract:
PURPOSE: An in situ implant composition is provided with a biodegradable polymer containing polyethylene glycol to prevent denaturation of the protein substance within the polymer matrix by forming the movement passage of carboxylic acid, and to control the structure and material property of the polymer by introducing polyethylene glycol. CONSTITUTION: An in situ implant composition contains a biodegradable polymer containing a copolymer of polyethylene glycol and aliphatic polyester, a solvent for dissolving the biodegradable polymer, and a medicament uniformly diffused in the solvent to mediate the biodegradable polymer. The aliphatic polyester polymer is selected from lactic acid, glycolic acid, caprolactone, dioxanone, or trimethyl carbonate. The copolymer is a graft or block copolymer.
Abstract:
Provided are an aliphatic polyester grafted with polyethylene glycol having a functional group which is biodegradable and whose content of the polyethylene glycol can be controlled easily, and its preparation method. The aliphatic polyester is represented by the formula 1, wherein X is an aliphatic ester repeating unit; R is H or a C1-C5 alkyl group; Z is the moiety of an initiator or a chain transfer agent; m/l is 0.1-50; n is an integer of 2-50; x is a positive integer; and y is an integer of 1-200. Preferably X is any one selected from the group consisting of lactide, glycolide, caprolactone, beta-propiolactone, gamma-butyrolactone and p-dioxanone. The method comprises the steps of ring opening polymerizing an aliphatic ester cyclic compound and an epoxy-based monomer having a double bond at an alkyl chain terminal; and radical polymerizing the polyethylene glycol where a certain polymerizable functional group is introduced with the obtained compound.